Working together to advance pathways in cardiovascular risk management Cardiovascular disease management requires commitment and innovation. Despite optimal management of risk factors such as low-density lipoprotein cholesterol (LDL-C), many patients remain at risk of cardiovascular events.¹ To reduce the burden of CVD, emerging therapeutic modalities should be explored to address drivers of residual risk.¹ To provide effective cardiovascular prevention, it is crucial to share information on the evolving CVD landscape and discuss central questions in CVD management. How can we fight cardiovascular disease today?